Arena Pharmaceuticals

Arena Pharmaceuticals, Inc.
Company typeSubsidiary
Nasdaq: ARNA
IndustryBiotechnology
Founded1997; 27 years ago (1997)
Founders
  • Jack Lief
  • Dominic Behan
Headquarters
San Diego, California
,
U.S.
Key people
  • Dominic Behan (senior scientist)
  • Amit Munshi (CEO)
  • Kevin Lind (CFO)
ProductsBelviq
RevenueIncreaseUS$27,600,000 (FY 2012)[1]
DecreaseUS$−57,000,000 (FY 2012)[1]
DecreaseUS$−85,500,000 (FY 2012)[1]
Total assetsIncreaseUS$261,000,000 (FY 2012)[2]
Total equityIncreaseUS$98,600,000 (FY 2012)[2]
ParentPfizer
Websitearenapharm.com

Arena Pharmaceuticals, Inc. is an American biopharmaceutical company founded in 1997 and headquartered in San Diego, California.[3] The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas. The company's most advanced investigational clinical programs are ralinepag (formerly APD811) in testing for pulmonary arterial hypertension (PAH), etrasimod (formerly APD334) in evaluation for inflammatory indications and APD371 for the treatment of pain associated with Crohn's disease.[4] In 2016, the company downsized and shifted its focus to developing new drugs currently being tested in clinical trials.[5][6] In December 2021, Pfizer announced that it had agreed to acquire Arena for $6.7 billion in cash.[7][8] In March 2022, it was announced the acquisition by Pfizer had been concluded.[9]

  1. ^ a b c Cite error: The named reference 2009IncomeStatmenent was invoked but never defined (see the help page).
  2. ^ a b Cite error: The named reference 2009BalanceSheet was invoked but never defined (see the help page).
  3. ^ "Arena Pharmaceutical, Inc" (PDF). Archived from the original (PDF) on November 16, 2016. Retrieved November 16, 2016.
  4. ^ "arna-10k_20161231.htm". www.sec.gov. Retrieved 2017-04-26.
  5. ^ Meiling, Brittany (July 4, 2016). "Arena Pharmaceuticals Is Slashing Its Workforce 73%". San Diego Business Journal. Retrieved 5 July 2016.
  6. ^ "Arena Axing 100 Employees, 73% of Workforce". News: Industry Watch (online: GEN News Highlights). Genetic Engineering & Biotechnology News. 36 (14): 10. August 2016. Retrieved 17 September 2016.
  7. ^ "Pfizer bets on Arena's promising bowel disease treatment in $6.7 bln deal". Reuters. December 13, 2021. Retrieved December 13, 2021.
  8. ^ Walker, Joseph (December 13, 2021). "Pfizer to Acquire Arena Pharmaceuticals in $6.7 Billion Deal". Wall Street Journal. Retrieved December 13, 2021.
  9. ^ "Pfizer concludes Arena Pharmaceuticals acquisition for $6.7bn". Pharmaceutical Technology. 2022-03-14. Retrieved 2022-03-14.